Literature DB >> 22198266

Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1.

Justin R Prigge1, Sofi Eriksson, Sonya V Iverson, Tesia A Meade, Mario R Capecchi, Elias S J Arnér, Edward E Schmidt.   

Abstract

Ribonucleotide reductase (RNR) activity requires an electron donor, which in bacteria, yeast, and plants is usually either reduced thioredoxin (Trx) or reduced glutaredoxin. Mice lacking glutathione reductase are viable and, although mice lacking thioredoxin reductase 1 (TrxR1) are embryonic-lethal, several studies have shown that mouse cells lacking the txnrd1 gene, encoding TrxR1, can proliferate normally. To better understand the in vivo electron donor requirements for mammalian RNR, we here investigated whether replication of TrxR1-deficient hepatocytes in mouse livers either employed an alternative source of Trx-reducing activity or, instead, solely relied upon the glutathione (GSH) pathway. Neither normal nor genetically TrxR1-deficient livers expressed substantial levels of mRNA splice forms encoding cytosolic variants of TrxR2, and the TrxR1-deficient livers showed severely diminished total TrxR activity, making it unlikely that any alternative TrxR enzyme activities complemented the genetic TrxR1 deficiency. To test whether the GSH pathway was required for replication, GSH levels were depleted by administration of buthionine sulfoximine (BSO) to juvenile mice. In controls not receiving BSO, replicative indexes were similar in hepatocytes having two, one, or no functional alleles of txnrd1. After BSO treatment, hepatocytes containing either two or one copies of this gene were also normal. However, hepatocytes completely lacking a functional txnrd1 gene exhibited severely reduced replicative indexes after GSH depletion. We conclude that hepatocyte proliferation in vivo requires either GSH or at least one functional allele of txnrd1, demonstrating that either the GSH- or the TrxR1-dependent redox pathway can independently support hepatocyte proliferation during liver growth.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22198266      PMCID: PMC3267845          DOI: 10.1016/j.freeradbiomed.2011.11.025

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  53 in total

1.  Human Protein Atlas of redox systems - what can be learnt?

Authors:  Pascal Dammeyer; Elias S J Arnér
Journal:  Biochim Biophys Acta       Date:  2010-07-18

2.  Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation.

Authors:  Pankaj Kumar Mandal; Manuela Schneider; Pirkko Kölle; Peter Kuhlencordt; Heidi Förster; Heike Beck; Georg W Bornkamm; Marcus Conrad
Journal:  Cancer Res       Date:  2010-11-02       Impact factor: 12.701

3.  Redox atlas of the mouse. Immunohistochemical detection of glutaredoxin-, peroxiredoxin-, and thioredoxin-family proteins in various tissues of the laboratory mouse.

Authors:  José Rodrigo Godoy; Maria Funke; Waltraud Ackermann; Petra Haunhorst; Sabrina Oesteritz; Francisco Capani; Hans-Peter Elsässer; Christopher Horst Lillig
Journal:  Biochim Biophys Acta       Date:  2010-06-01

4.  Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration.

Authors:  MaryClare F Rollins; Dana M van der Heide; Carla M Weisend; Jean A Kundert; Kristin M Comstock; Elena S Suvorova; Mario R Capecchi; Gary F Merrill; Edward E Schmidt
Journal:  J Cell Sci       Date:  2010-06-22       Impact factor: 5.285

5.  Selenoprotein TRXR-1 and GSR-1 are essential for removal of old cuticle during molting in Caenorhabditis elegans.

Authors:  Jörgen Stenvall; Juan Carlos Fierro-González; Peter Swoboda; Karunakar Saamarthy; Qing Cheng; Briseida Cacho-Valadez; Elias S J Arnér; Olof P Persson; Antonio Miranda-Vizuete; Simon Tuck
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-03       Impact factor: 11.205

Review 6.  Antioxidant function of thioredoxin and glutaredoxin systems.

Authors:  A Holmgren
Journal:  Antioxid Redox Signal       Date:  2000       Impact factor: 8.401

7.  Contributions of new hepatocyte lineages to liver growth, maintenance, and regeneration in mice.

Authors:  Sonya V Iverson; Kristin M Comstock; Jean A Kundert; Edward E Schmidt
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

Review 8.  Physiological functions of thioredoxin and thioredoxin reductase.

Authors:  E S Arnér; A Holmgren
Journal:  Eur J Biochem       Date:  2000-10

9.  Cre activity in fetal albCre mouse hepatocytes: Utility for developmental studies.

Authors:  Carla M Weisend; Jean A Kundert; Elena S Suvorova; Justin R Prigge; Edward E Schmidt
Journal:  Genesis       Date:  2009-12       Impact factor: 2.487

10.  The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice.

Authors:  Larisa Nonn; Ryan R Williams; Robert P Erickson; Garth Powis
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

View more
  34 in total

1.  Non-enzymatic action of RRM1 protein upregulates PTEN leading to inhibition of colorectal cancer metastasis.

Authors:  Hongyan Qi; Meng Lou; Yuexia Chen; Xiyong Liu; Naiming Chen; Jianzhen Shan; Zhiqiang Ling; Jing Shen; Lijun Zhu; Yun Yen; Shu Zheng; Jimin Shao
Journal:  Tumour Biol       Date:  2015-02-01

2.  Type I IFNs Act upon Hematopoietic Progenitors To Protect and Maintain Hematopoiesis during Pneumocystis Lung Infection in Mice.

Authors:  Justin R Prigge; Teri R Hoyt; Erin Dobrinen; Mario R Capecchi; Edward E Schmidt; Nicole Meissner
Journal:  J Immunol       Date:  2015-10-30       Impact factor: 5.422

Review 3.  The A to Z of modulated cell patterning by mammalian thioredoxin reductases.

Authors:  Markus Dagnell; Edward E Schmidt; Elias S J Arnér
Journal:  Free Radic Biol Med       Date:  2017-12-24       Impact factor: 7.376

4.  Thioredoxin Reductase Inhibition Attenuates Neonatal Hyperoxic Lung Injury and Enhances Nuclear Factor E2-Related Factor 2 Activation.

Authors:  Qian Li; Stephanie B Wall; Changchun Ren; Markus Velten; Cynthia L Hill; Morgan L Locy; Lynette K Rogers; Trent E Tipple
Journal:  Am J Respir Cell Mol Biol       Date:  2016-09       Impact factor: 6.914

5.  Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.

Authors:  Yatao Du; Huihui Zhang; Jun Lu; Arne Holmgren
Journal:  J Biol Chem       Date:  2012-09-13       Impact factor: 5.157

6.  Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.

Authors:  William C Stafford; Xiaoxiao Peng; Maria Hägg Olofsson; Xiaonan Zhang; Diane K Luci; Li Lu; Qing Cheng; Lionel Trésaugues; Thomas S Dexheimer; Nathan P Coussens; Martin Augsten; Hanna-Stina Martinsson Ahlzén; Owe Orwar; Arne Östman; Sharon Stone-Elander; David J Maloney; Ajit Jadhav; Anton Simeonov; Stig Linder; Elias S J Arnér
Journal:  Sci Transl Med       Date:  2018-02-14       Impact factor: 17.956

Review 7.  Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications.

Authors:  Xin Gen Lei; Jian-Hong Zhu; Wen-Hsing Cheng; Yongping Bao; Ye-Shih Ho; Amit R Reddi; Arne Holmgren; Elias S J Arnér
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 8.  The thioredoxin system in neonatal lung disease.

Authors:  Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2014-03-13       Impact factor: 8.401

9.  The thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndrome.

Authors:  Rodney D Britt; Markus Velten; Morgan L Locy; Lynette K Rogers; Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

Review 10.  Dual targeting of the thioredoxin and glutathione systems in cancer and HIV.

Authors:  Moran Benhar; Iart Luca Shytaj; Jonathan S Stamler; Andrea Savarino
Journal:  J Clin Invest       Date:  2016-05-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.